Korro Bio, Inc.
KRRO
$20.26
$0.190.95%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.07% | -19.58% | 16.62% | -13.56% | -23.67% |
| Total Depreciation and Amortization | 70.18% | 68.73% | 27.21% | -5.88% | -21.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.69% | -23.65% | -49.56% | -24.56% | 49.49% |
| Change in Net Operating Assets | -31.65% | 24.55% | 1,283.29% | -32.33% | 520.75% |
| Cash from Operations | -31.76% | -11.70% | 64.49% | -36.72% | 0.83% |
| Capital Expenditure | 97.65% | 97.88% | 12.27% | -1,882.93% | -34.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 88.43% | -- | -- | -870.00% | -9,743.20% |
| Cash from Investing | 88.96% | 684.23% | -67.07% | -1,768.17% | -2,892.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.99% | 23.74% | -99.40% | 237.04% | 82,285.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.99% | 23.74% | -99.36% | 133.21% | 187,755.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.23% | 131.07% | -107.66% | -111.54% | -172.00% |